The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]
Open accessAbstract
Germline mutations in the p16 and CDK4 genes have been reported in a subset of melanoma pedigrees, but their prevalence is not well known. We searched for such germline mutations in 48 French melanoma-prone families selected according to two major criteria: families with at least three affected members (n = 20) or families with two affected members, one of them affected before the age of 50 (n = 28), and one additional minor criterion. Sixteen different p16 germline mutations were found in 21 families, while one germline mutation, Arg24His, was detected in the CDK4 gene. The frequency of p16 gene mutation in our sample (44%) is among the highest rates yet reported and the CDK4 mutation is the second mutation detected in this gene worldwide. In summary, our results show frequent involvement of the p16 gene in familial melanoma and confirm the role of the CDK4 gene as a melanoma-predisposing gene.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Parker, S. L., Tong, T., Bolden, S., & Wingo, P. A. (1997) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.47.1.5 · Cited by 2,003
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,986
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Büschenfelde, K.-H., & Beach, D. (1995) · Science · doi:10.1126/science.7652577 · Cited by 1,154
Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,136
Germline p16 mutations in familial melanoma
Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M. A., & Dracopoli, N. C. (1994) · Nature Genetics · doi:10.1038/ng0994-15 · Cited by 977
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., & Bartek, J. (1995) · Nature · doi:10.1038/375503a0 · Cited by 899
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
Kamb, A., Shattuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N. A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver-Feldhaus, J., et al. (1994) · Nature Genetics · doi:10.1038/ng0994-22 · Cited by 855
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
Zuo, L., Weger, J., Yang, Q., Goldstein, A. M., Tucker, M. A., Walker, G. J., Hayward, N., & Dracopoli, N. C. (1996) · Nature Genetics · doi:10.1038/ng0196-97 · Cited by 818 · cited 3×
“Germline mutations segregate with the phenotype in melanoma kindreds (20, 21 ).”
BackgroundMethodInfluentialGenetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
(1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60352-8 · Cited by 752
Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds with p16INK4Mutations
Goldstein, A. M., Fraser, M. C., Struewing, J. P., Hussussian, C. J., Ranade, K., Zametkin, D. P., Fontaine, L. S., Organic, S. M., Dracopoli, N. C., Clark, W. H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331504 · Cited by 622
Assignment of a Locus for Familial Melanoma, MLM, to Chromosome 9p13-p22
Cannon-Albright, L. A., Goldgar, D. E., Meyer, L. J., Lewis, C. M., Anderson, D. E., Fountain, J. W., Hegi, M. E., Wiseman, R. W., Petty, E. M., Bale, A. E., et al. (1992) · Science · doi:10.1126/science.1439824 · Cited by 524
Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition
Koh, J., Enders, G. H., David Dynlacht, B., & Harlow, E. (1995) · Nature · doi:10.1038/375506a0 · Cited by 516
Inhibition of Ras-Induced Proliferation and Cellular Transformation by p16 INK4
Serrano, M., Gómez-Lahoz, E., DePinho, R. A., Beach, D., & Bar-Sagi, D. (1995) · Science · doi:10.1126/science.7809631 · Cited by 373
Homozygous deletions within human chromosome band 9p21 in melanoma.
Fountain, J. W., Karayiorgou, M., Ernstoff, M. S., Kirkwood, J. M., Vlock, D. R., Titus-Ernstoff, L., Bouchard, B., Vijayasaradhi, S., Houghton, A. N., & Lahti, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10557 · Cited by 315
Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds
Gruis, N. A., van der Velden, P. A., Sandkuijl, L. A., Prins, D. E., Weaver-Feldhaus, J., Kamb, A., Bergman, W., & Frants, R. R. (1995) · Nature Genetics · doi:10.1038/ng0795-351 · Cited by 310
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-2-280_1 · Cited by 304
Mutations associated with familial melanoma impair p16INK4 function
Ranade, K., Hussussian, C. J., Sikorski, R. S., Varmus, H. E., Goldstein, A. M., Tucker, M. A., Serrano, M., Hannon, G. J., Beach, D., & Dracopoli, N. C. (1995) · Nature Genetics · doi:10.1038/ng0595-114 · Cited by 280 · cited 1×
“In the absence of functional tests, such as studying the ability of mutant P16 proteins to bind in vitro to CDK4 protein ( 47 ), we can only make presumptions based on concordant observations.”
BackgroundWhelan, A. J., Bartsch, D., & Goodfellow, P. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331505 · Cited by 280
Cloning and characterization of murine p16INK4a and p15INK4b genes.
Quelle, D. E., Ashmun, R. A., Hannon, G. J., Rehberger, P. A., Trono, D., Richter, K. H., Walker, C., Beach, D., Sherr, C. J., & Serrano, M. (1995) · PubMed · Cited by 235
Quelle, D. E., Cheng, M., Ashmun, R. A., & Sherr, C. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.669 · Cited by 220
FitzGerald, M. G., Harkin, D. P., Silva-Arrieta, S., MacDonald, D. J., Lucchina, L. C., Unsal, H., O'Neill, E., Koh, J., Finkelstein, D. M., Isselbacher, K. J., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8541 · Cited by 200
Pollock, P. M., Pearson, J. V., & Hayward, N. K. (1996) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199602)15:2<77::aid-gcc1>3.0.co;2-0 · Cited by 189
Fåhraeus, R., Paramio, J. M., Ball, K. L., Laín, S., & Lane, D. P. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00425-6 · Cited by 170
Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
Flores, J. F., Walker, G. J., Glendening, J. M., Haluska, F. G., Castresana, J. S., Rubio, M., Pastorfide, G. C., Boyer, L. A., Kao, W. H., Bulyk, M. L., et al. (1996) · PubMed · Cited by 169
Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers.
Yoshida, S., Todoroki, T., Ichikawa, Y., Hanai, S., Suzuki, H., Hori, M., Fukao, K., Miwa, M., & Uchida, K. (1995) · PubMed · doi:10.11501/3164579 · Cited by 168
Platz, A., Hansson, J., Månsson‐Brahme, E., Lagerlöf, B., Linder, S., Ringborg, U. K., Lundqvist, E., Sevigny, P., & Inganäs, M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.10.697 · Cited by 163
Systemic cancer and the FAMMM syndrome
Bergman, W., Watson, P., de Jong, J., Lynch, H., & Fusaro, R. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.209 · Cited by 160
Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds
Walker, G. J., Hussussian, C. J., Flores, J. F., Glendening, M. J., Haluska, F. G., Dracopoli, N. C., Hayward, N. K., & Fountain, J. W. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.10.1845 · Cited by 141
p16 gene homozygous deletions in acute lymphoblastic leukemia
Quesnel, B., Preudhomme, C., Philippe, N., Vanrumbeke, M., Dervite, I., Laï, J., Bauters, F., Wattel, E., & Fenaux, P. (1995) · Blood · doi:10.1182/blood.v85.3.657.bloodjournal853657 · Cited by 139
Naumann, M., Савицкая, Н. Г., Eilert-Micus, C., Schramm, A. R., Kalthoff, H., & Schmiegel, W. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613012 · Cited by 122
Gruis, N. A., Sandkuijl, L. A., van der Velden, P. A., Bergman, W., & Frants, R. R. (1995) · Melanoma Research · doi:10.1097/00008390-199506000-00005 · Cited by 110
Goldstein, A. M., Dracopoli, N. C., Ho, E. C., Fraser, M. C., Kearns, K. S., Bale, S. J., McBride, O. W., Clark, W. H., & Tucker, M. A. (1993) · Europe PMC (PubMed Central) · Cited by 109
Goldstein, A. M., Dracopoli, N. C., Engelstein, M., Fraser, M. C., Clark, W. H., & Tucker, M. A. (1994) · PubMed Central · Cited by 105
Temperature-Sensitive Mutants of p16CDKN2 Associated with Familial Melanoma
Parry, D., & Peters, G. G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3844 · Cited by 104
Genomic structure, expression and mutational analysis of the P15 (MTS2) gene.
Stone, S., Dayananth, P., Jiang, P., Weaver-Feldhaus, J., Tavtigian, S. V., Cannon‐Albright, L., & Kamb, A. (1995) · PubMed · Cited by 103
Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds.
Holland, E. A., Beaton, S. C., Becker, T. M., Grulet, O., Peters, B. A., Rizos, H., Kefford, R. F., & Mann, G. J. (1995) · PubMed · Cited by 101
Novel germline p16 mutation in familial malignant melanoma in southern Sweden.
Borg, Å., Johannsson, U., Jóhannsson, Ó. Þ., Häkansson, S., Westerdahl, J., Måsbäck, A., Olsson, H. L., & Ingvar, C. (1996) · PubMed · Cited by 101
Confirmation of chromosome 9p linkage in familial melanoma.
Nancarrow, D. J., Mann, G. J., Holland, E. A., Walker, G. J., Beaton, S. C., Walters, M. K., Luxford, C., Palmer, J. M., Donald, J. A., & Weber, J. L. (1993) · PubMed · Cited by 96
Lazar, V., Grandjouan, S., Bognel, C., Couturier, D., Rougier, P. R., Bellet, D. H., & Paillerets, B. B. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.12.2257 · Cited by 93
Mutational effects on the p16INK4a tumor suppressor protein.
Yang, R., Gombart, A. F., Serrano, M., & Koeffler, H. P. (1995) · PubMed · Cited by 92
p16/CDKN2 andCDK4 gene mutations in sporadic melanoma development and progression
Piccinin, S., Doglioni, C., Maestro, R., Vukosavijevic, T., Gasparotto, D., D'Orazi, C., & Boiocchi, M. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970220)74:1<26::aid-ijc5>3.0.co;2-2 · Cited by 85
Cancer-associated mis-sense and deletion mutations impair p16INK4 CDK inhibitory activity
Lilischkis, R., Šarčević, B., Kennedy, C. J., Warlters, A., & Sutherland, R. L. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960410)66:2<249::aid-ijc19>3.0.co;2-7 · Cited by 81
Familial Tumor Syndrome Associated With a Germline Nonfunctional p16INK4a Allele
Yarbrough, W. G., Aprelikova, O. N., Pei, H., Olshan, A. F., & Liu, E. T. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1489 · Cited by 70
Petty, E. M., Gibson, L. H., Fountain, J. W., Bolognia, J. L., Yang‐Feng, T. L., Housman, D. E., & Bale, A. E. (1993) · PubMed · Cited by 66
Genetic heterogeneity in familial malignant melanoma
MacGeoch, C., Newton‐Bishop, J., Batallle, V., Bishop, D. T., Frischauf, A.-M., Melonl, R., Cuzlck, J., Plnney, E., & Spurr, N. K. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.12.2195 · Cited by 63
The Queensland Familial Melanoma Project
Aitken, J. F., Green, A. C., MacLennan, R., Youl, P., & Martin, N. G. (1996) · Melanoma Research · doi:10.1097/00008390-199604000-00011 · Cited by 51
Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi.
Goldstein, A. M., Goldin, L. R., Dracopoli, N. C., Clark, W. H., & Tucker, M. A. (1996) · PubMed · Cited by 51
Liu, L., Goldstein, A. M., Tucker, M. A., Brill, H., Gruis, N. A., Hogg, D., & Lassam, N. J. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199705)19:1<52::aid-gcc8>3.0.co;2-# · Cited by 47
Biochemical and mutagenic analysis of the melanoma tumor suppressor gene product/p16.
Wick, S. T., Dubay, M., Imanil, I., & Brizuela, L. (1995) · PubMed · Cited by 36
Analysis of p16INK4aand Its Interaction with CDK4
Yang, R., Serrano, M., Slater, J., Leung, E., & Koeffler, H. P. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0045 · Cited by 29
Cited by
The p16INK4a/CDKN2A tumor suppressor and its relatives
Ruas, M., & Peters, G. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00017-1 · Cited by 911
Malignant melanoma: genetics and therapeutics in the genomic era
Chin, L., Garraway, L. A., & Fisher, D. E. (2006) · Genes & Development · doi:10.1101/gad.1437206 · Cited by 511
Geographical Variation in the Penetrance of CDKN2A Mutations for Melanoma
Bishop, D. T. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.12.894 · Cited by 509
Melanoma: from mutations to medicine
Tsao, H., Chin, L., Garraway, L. A., & Fisher, D. E. (2012) · Genes & Development · doi:10.1101/gad.191999.112 · Cited by 496
Goldstein, A. M., Chan, M., Harland, M., Hayward, N. K., Demenais, F., Timothy Bishop, D., Azizi, E., Bergman, W., Bianchi-Scarra, G., Bruno, W., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2006.043802 · Cited by 453
Metadata
- Authors
- Soufir, N.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-02-01
- Volume
- 7
- Issue
- 2
- Pages
- 209-216
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W1946633045
- Cited by
- 386
- References
- 54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.